Lidocaína Medinfar (Lidocaine Hydrochloride)

Lidocaine hydrochloride works by reversibly binding to voltage‑gated sodium channels on peripheral nerve membranes. This binding stabilizes the inactive channel state, preventing sodium influx that is necessary for depolarization, thereby inhibiting the initiation and conduction of nerve impulses and producing localized anesthesia.

The appropriate dose of Lidocaína Medinfar is determined by the prescribing clinician based on the specific procedure, patient weight, and clinical context. Healthcare professionals calculate the amount needed to achieve effective anesthesia while staying within recommended maximum limits to avoid systemic toxicity.

Safety data for lidocaine hydrochloride in pregnancy and lactation are limited. It should be used only when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision should be made by a qualified healthcare provider.

To order Lidocaína Medinfar, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details (including any cold‑chain requirements), and import documentation.

Lidocaína Medinfar contains lidocaine, an amide‑type local anesthetic known for rapid onset and moderate duration of action. Compared with ester‑type agents such as procaine, lidocaine generally provides a faster onset, longer analgesic window, and a lower incidence of allergic reactions, making it a common choice for short‑to‑moderate procedures.

Lidocaína Medinfar should be stored at ambient temperature, preferably below 25 °C. Keep the vial in its original packaging, protect it from moisture and direct sunlight, and avoid freezing. Inspect the solution for any particulate matter or discoloration before use.

Lidocaína Medinfar is administered by subcutaneous injection. The healthcare professional selects an appropriate injection site, cleans the area with an antiseptic, and injects the calculated volume slowly to achieve the desired anesthetic effect while monitoring the patient for any immediate reactions.

Serious risks include allergic reactions such as urticaria, angioedema, or anaphylaxis, as well as cardiovascular toxicity (hypotension, bradycardia, arrhythmias) and central nervous system toxicity (seizures, loss of consciousness). Prompt recognition and emergency management are essential if these events occur.

Patients with a known hypersensitivity to lidocaine or other amide‑type local anesthetics, those with severe heart block, uncontrolled arrhythmias, or significant hepatic impairment should avoid using Lidocaína Medinfar. Additionally, it is contraindicated in individuals for whom the prescriber determines the risks outweigh any potential benefit.